Home > Press > Aculon Receives Patent for Application of Organophosphorus Treatments to Cutting Tools
Abstract:
Aculon, Inc., a leading nanotechnology enabled performance coatings company, today announced that the United States Patent and Trademark Office (USPTO) has allowed a patent covering its method for applying organophosphorus acids to cutting tools.
United States Patent Application No. 12,080,058 discloses the process required for applying organophosphorus acids having a fluorinated constituent to cutting tools and razors. The organophosphorus fluorinated material can either be adhered directly to the metal edge or indirectly to through an intermediary organometallic layer. The invention also provides for a method of depositing the organophosphorus fluorinated material as a self assembled monolayer or as a multilayer treatment.
"We believe that this technology offers a significant advantage to the current thick polymer based treatments currently available for cutting tools such as razor blades." comments Edward Hughes, CEO of Aculon.
####
About Aculon, Inc.
Founded in 2004, Aculon specializes in inventing and commercializing unique molecular-scale surface and interfacial coatings leveraging nanotechnology discoveries made at Princeton University. The Company's breakthrough technology outperforms all known alternatives in characteristics such as repellency, particle treatments, and adhesion.
Key benefits of Aculon technology include:
- Repellency ˆ Treat numerous surfaces to repel water, oil, solvents, and most all liquids.
- Particle Treatment ˆ Functionalize nanoparticles to improve many characteristics such as hydrophobicity, oleophobicity, and adhesion.
- Adhesion ˆ Boost the adhesion of challenging surfaces with Aculon‚s adhesion promoting treatments.
- Value - Molecular scale modification can transform surfaces and interfaces to provide unique performance, simpler processes, and favorable economics.
Aculon's team brings together seasoned executives from the specialty chemicals industry, professional investors experienced in early-stage technology companies, key scientists from Princeton University, and proven business development professionals.
For more information, please click here
Contacts:
Mario Gattuso
Phone: 858-350-9474
Copyright © Aculon Inc
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Self Assembly
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Liquid crystal templated chiral nanomaterials October 14th, 2022
Nanoclusters self-organize into centimeter-scale hierarchical assemblies April 22nd, 2022
Atom by atom: building precise smaller nanoparticles with templates March 4th, 2022
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||